Estimation of Vitamin A Stores in Children and Women in Guatemala and Relation With Potential Toxicity Markers
GloVitAS-GU
LOAEL/NOAEL and UL Determination in Guatemala - Estimation of Vitamin A Stores in Children and Women and Correlation With Potential Toxicity Markers
1 other identifier
observational
178
1 country
3
Brief Summary
The goal of this study is to assess whether 3-5 years-old children who have Vitamin A intakes above the tolerable upper intake level (UL=900 ug per day) have higher total body Vitamin A stores and biomarkers of excessive vitamin A status, compared to children with Normal Vitamin A intakes (250-600 ug per day).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2017
Shorter than P25 for all trials
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 13, 2017
CompletedFirst Submitted
Initial submission to the registry
August 25, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 13, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
October 30, 2017
CompletedFirst Posted
Study publicly available on registry
November 17, 2017
CompletedNovember 17, 2017
November 1, 2017
8 months
August 25, 2017
November 13, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Total Vitamin A stores among 3-5 years-old children, in micromoles
Estimated using Carbon 13 (13C) 13C-retinol dilution method, by the ratio of Labelled (stable isotope) versus no labelled Vitamin A in plasma 4 days after dose of labelled VA is given.
28-day study period
Total dietary vitamin A intake among 3-5 years-old children, in micrograms (ug)
Estimated using 24-hour dietary recalls, observed weigh food records, food and supplement frequency questionnaire
28-day study period
Secondary Outcomes (9)
Plasma retinol among 3-5 years-old children
28-day study period
Plasma retinol binding protein among 3-5 years-old children
28-day study period
Plasma Transthyretin among 3-5 years-old children
28-day study period
Bone Health markers among 3-5 years-old children
28-day study period
Liver function markers among 3-5 years-old children
28-day study period
- +4 more secondary outcomes
Other Outcomes (5)
Hemoglobin concentration in children
At recruitment
Children weight and length
At recruitment
Systemic inflammation in children
At recruitment
- +2 more other outcomes
Study Arms (2)
Normal Vitamin A intake
Normal Vitamin A intake will be assessed by a questionnaire directed to the consumption of food items with high VA content on the 7 days prior to the questionnaire. The daily consumption will be assessed on average. A child is assigned to Normal Vit. A consumption if daily Vit. A is between 250 and 600 micrograms per day.
High Vitamin A intake
High Vitamin A intake will be assessed by a questionnaire directed to the consumption of food items with high VA content on the 7 days prior to the questionnaire. The daily consumption will be assessed on average. A child is assigned to High Vit. A consumption if daily Vit. A is above 900 micrograms per day.
Interventions
Total Vitamin A stores will be assessed by isotopic measurement, 13C-Retinol will be given to the subject and blood wil be drawn on Day 4 to assess the isotopic dilution in the plasma. Other biochemical indicators will be assessed too, along with Dietary assessment (Food Frequency, 24 hours recalls).
Total Vitamin A stores will be assessed by isotopic measurement, 13C-Retinol will be given to the subject and blood wil be drawn on Day 4 to assess the isotopic dilution in the plasma. Other biochemical indicators will be assessed too, along with Dietary assessment (Food Frequency, 24 hours recalls).
Eligibility Criteria
Children and Women from Guatemala peri-urban areas or areas where High Vitamin A foods intake is reported. Convenience sampling according to the availability (time to participate in the study) of the participant, and acceptance of Blood sampling and Dietary assessments
You may qualify if:
- Children 3-5 years old and their mothers
- Child VA intake must be above 250 micrograms/day
- Children must be apparently healthy, Hemoglobin\>9 g/dL at recruitment point, C-reactive protein\<5 mg/L. For Women, Hemoglobin\>10 g/dL, C-reactive protein\<5 mg/L
You may not qualify if:
- °Children with Congenital or chronical diseases, reported illnesses 1 week before the test. For Women: Pregnancy or lactation, Previously known Chronic Diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Institute of Nutrition of Central America and Panamalead
- Newcastle Universitycollaborator
- Bill and Melinda Gates Foundationcollaborator
- International Atomic Energy Agencycollaborator
Study Sites (3)
Mixco, La Comunidad City Hall
Guatemala City, Guatemala
Sacatepequez City Hall
Guatemala City, Guatemala
Santa Catarina Pinula City Hall
Guatemala City, Guatemala
Related Publications (1)
Ford JL, Green JB, Haskell MJ, Ahmad SM, Mazariegos Cordero DI, Oxley A, Engle-Stone R, Lietz G, Green MH. Use of Model-Based Compartmental Analysis and a Super-Child Design to Study Whole-Body Retinol Kinetics and Vitamin A Total Body Stores in Children from 3 Lower-Income Countries. J Nutr. 2020 Feb 1;150(2):411-418. doi: 10.1093/jn/nxz225.
PMID: 31535129DERIVED
Biospecimen
Venous blood will be drawn on Day 4 post C-13 Vitamin A administration (women and children) and one variable day (children only) to obtain plasma, serum, and buffy coat (Day 4), or only plasma on variable day post Vitamin A dose for children.
Study Officials
- PRINCIPAL INVESTIGATOR
Dora I Mazariegos, MsSc
Institute of Nutrition of Central America and Panama
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher, Nutritional Biochemistry Laboratory
Study Record Dates
First Submitted
August 25, 2017
First Posted
November 17, 2017
Study Start
January 13, 2017
Primary Completion
September 13, 2017
Study Completion
October 30, 2017
Last Updated
November 17, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, CSR, ANALYTIC CODE
- Time Frame
- Data will become available when, after study data collection is finished, data are cleaned and analyzed.
- Access Criteria
- All pre-defined researchers will have access to database. This includes Georg Lietz, principal coordinator, and local Principal researchers.
All Collected individual participant data (IPD) will be shared within the researchers group of the Global Project (GLOVITAS, leaded by Newcastle University). Only initials will identify individual participants and the information shared will be on biochemical markers, diet, and general socioeconomic data.